Chronic Kidney Disease Trial, Recruiting NCT06898294 Sponsor: The University of Hong Kong Condition: Chronic Kidney Disease
Back to Chronic Kidney Disease

Chronic Kidney Disease Trial, Recruiting

NCT06898294
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been clinically diagnosed with chronic kidney disease (CKD) at any stage (stage 1 through 5), based on kidney function test results
  • People between 18 and 90 years of age, of any gender

Who may not be able to join:

  • People in the control group (comparison group) who have a known kidney disease or kidney abnormality
  • People who have previously had any type of kidney surgery or a kidney transplant
  • People who have damaged or broken skin on their abdomen (stomach area)
  • People who have an implanted electronic device (such as a pacemaker)
  • People who have a spinal condition or back/spine discomfort
  • People who have had any abdominal (stomach area) surgery recently
  • People who are pregnant
  • People with a BMI (body mass index) over 35, which is a measure of body weight relative to height
  • People who have uncontrollable involuntary body movements, such as those caused by conditions like Alzheimer's disease, Parkinson's disease, epilepsy, stroke, cerebral palsy, tardive dyskinesia, tremors, or similar neurological or seizure-related conditions

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Yat Hin, Desmond Yap, PhD, MD, The University of Hong Kong

Phone: 22554385

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 September 2021
Est. completion
31 August 2025

Where this trial is recruiting

Hong Kong

Primary endpoints

Identification of optimal EIT current injection frequencies for kidney function assessment; Functional assessment comparison between GFR measurement and EIT-Kidney scanning; Demographics, clinical assessments, and patient history analysis

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov